Short answer · Medically reviewed summary · Last updated: 2026-04-07
TL;DR: Hermansky-Pudlak syndrome is primarily diagnosed through a combination of clinical evaluation for oculocutaneous albinism and bleeding diathesis, followed by confirmatory molecular genetic testing. Because it is a rare, multi-system disorder, definitive diagnosis often requires specialized consultation with hematologists, geneticists, and ophthalmologists to identify specific mutations in one of the known HPS-related genes. How is Hermansky-Pudlak syndrome diagnosed? The diagnostic process for Hermansky-Pudlak syndrome (HPS) usually begins when a physician notices the triad of oculocutaneous albinism, a history of easy bruising or prolonged bleeding, and potentially symptoms of pulmonary fibrosis or colitis.
TL;DR: Hermansky-Pudlak syndrome is primarily diagnosed through a combination of clinical evaluation for oculocutaneous albinism and bleeding diathesis, followed by confirmatory molecular genetic testing. Because it is a rare, multi-system disorder, definitive diagnosis often requires specialized consultation with hematologists, geneticists, and ophthalmologists to identify specific mutations in one of the known HPS-related genes.
The diagnostic process for Hermansky-Pudlak syndrome (HPS) usually begins when a physician notices the triad of oculocutaneous albinism, a history of easy bruising or prolonged bleeding, and potentially symptoms of pulmonary fibrosis or colitis. Because Hermansky-Pudlak syndrome is a group of rare genetic disorders, there is no single "standard" test that catches every case immediately. Clinicians typically follow a structured diagnostic pathway:
Many patients within the Hermansky-Pudlak syndrome community, including the 8 members currently sharing their experiences on DiseaseMaps.org, report a frustrating "diagnostic odyssey." Because the condition is so rare—with some subtypes having an estimated prevalence of 1 in 500,000 to 1,000,000—many general practitioners may never encounter a case. Patients are often misdiagnosed with simple albinism or common bleeding disorders like von Willebrand disease before the full systemic nature of Hermansky-Pudlak syndrome is recognized. This delay can lead to significant emotional distress, and we want to validate that your frustration is a common and understandable response to the complexity of this rare disease.
Receiving an accurate diagnosis of Hermansky-Pudlak syndrome almost always requires a multi-disciplinary team. You should seek out specialists who have experience with rare genetic or hematological conditions. The core team typically includes:
Differential diagnosis is critical, as Hermansky-Pudlak syndrome can be confused with other disorders that cause hypopigmentation or bleeding. These include Chediak-Higashi syndrome, Griscelli syndrome, and various forms of non-syndromic oculocutaneous albinism. Distinguishing between these is vital, as the long-term systemic risks—such as the risk of lung disease—are unique to HPS.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.